Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SONIQ trial of choice-based nicotine replacement therapy for smoking cessation
ACTRN12606000451505Phase 3Completed
- Sponsor
- University of Auckland
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nicotine in nicotine dependence (2 arms), sponsored by University of Auckland. Primary endpoint: 7-day point prevalence abstinence. Started Mar 2007; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12606000451505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000451505.